|
| |||||||||||||||||||||||||||||||||||||||||||||||||
December 2007, Vol. 13, No. 3Focus on: Endocrine
Disruptors
A recent scientific review authored by Population Council biomedical researchers has detailed the ways that chemical plasticizers damage the testosterone-producing Leydig cells. These chemicals, known as phthalates, are added to plastics to increase their flexibility. Phthalates are found in products as diverse as children’s toys, medical tubing, and shampoo bottles. These findings have numerous implications for male fertility and health. The review was written by Population Council biomedical researchers Matthew P. Hardy, Ren-Shan Ge, and Cigdem Tanrikut, along with Guo-Rong Chen of China’s Wenzhou Medical College, and appeared in the journal Reproductive Toxicology. A related article appeared in the Chinese-language National Journal of Andrology.
Testicular
dysgenesis syndrome Studies by Hardy and others have shown that phthalates can affect Leydig cells in complicated ways at every stage of their development. Phthalates disrupt the production by Leydig cells of both testosterone and insulin-like growth factor 3 (INSL3). Phthalate interference with these substances could result in undescended testes. “The binding of INSL3 with a specific receptor, together with testosterone, is the trigger that causes the testes to descend from inside the abdomen, where they developed during gestation, to the scrotum outside the body,” explains Ren-Shan Ge, a biologist in the Hardy lab and author on the recent study. The disturbance of testosterone production by phthalates could also lead to impaired sperm production. In their recent summary, the Hardy team states that their studies, and studies from other laboratories, are building an evidence base showing that phthalates do not disrupt the endocrine, or hormonal, system by binding to hormone receptors, which is the way that many other endocrine disruptors operate. Phthalates instead seem to “alter reproductive function by affecting hormone synthesis,” according to Hardy and his co-authors. In many cases, screening assays that detect interference with hormone receptors have been used to evaluate potential endocrine disruptors. However, the team concludes, alternative tests may be needed in the case of phthalates. Sources Ge, Ren-Shan, Guo-Rong Chen, Cigdem Tanrikut, and Matthew P. Hardy. 2007. “Phthalate ester toxicity in Leydig cells: Developmental timing and dosage considerations,” Reproductive Toxicology 23(3): 366–373. Outside funding Related Project See Also
|
||||||||||||||||||||||||||||||||||||||||||||||||||